(Q45236849)

11 December 2017

title

High-volume ovarian cancer care: survival impact and disparities in access for advanced-stage disease (English)

1 reference

11 December 2017

1 reference

5

Hoda Anton-Culver

1 reference

11 December 2017

3

Argyrios Ziogas

1 reference

11 December 2017

Robert E Bristow

1

1 reference

11 December 2017

Jenny Chang

series ordinal

2

1 reference

11 December 2017

Leslie M Randall

series ordinal

4

1 reference

11 December 2017

language of work or name

English

0 references

publication date

20 December 2013

1 reference

11 December 2017

1 reference

11 December 2017

volume

132

1 reference

11 December 2017

issue

2

1 reference

11 December 2017

page(s)

403-410

1 reference

11 December 2017

cites work

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

National Institutes of Health Consensus Development Conference Statement. Ovarian cancer: screening, treatment, and follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Committee Opinion No. 477: the role of the obstetrician-gynecologist in the early detection of epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

What happens to racial and ethnic minorities after cancer surgery at American College of Surgeons National Surgical Quality Improvement Program hospitals?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Do racial/ethnic disparities exist in the utilization of high-volume surgeons for women with ovarian cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Validation of self-reported cancers in the California Teachers Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Ovarian cancer: patterns of surgical care across the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Predictors of comprehensive surgical treatment in patients with ovarian cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Impact of surgeon and hospital ovarian cancer surgical case volume on in-hospital mortality and related short-term outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Socioeconomic status and breast cancer incidence in California for different race/ethnic groups

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Poverty, culture, and social injustice: determinants of cancer disparities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Racial disparities in ovarian cancer surgical care: a population-based analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Disparities in ovarian cancer care quality and survival according to race and socioeconomic status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

7 January 2021

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Have racial disparities in ovarian cancer increased over time? An analysis of SEER data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Disparities in the utilization of high-volume hospitals for complex surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Racial and ethnic differences in the use of high-volume hospitals and surgeons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Evidence of benefit from centralised treatment of ovarian cancer: a nationwide population-based survival analysis in Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

The effect of centralization of primary surgery on survival in ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Influence of department volume on survival for ovarian cancer: results from a prospective quality assurance program of the Austrian Association for Gynecologic Oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Influence of hospital procedure volume on ovarian cancer survival in Japan, a country with low incidence of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Failure to rescue as a source of variation in hospital mortality for ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Adherence to treatment guidelines for ovarian cancer as a measure of quality care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Global ovarian cancer health disparities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Race does not impact outcome for advanced ovarian cancer patients treated with cisplatin/paclitaxel: an analysis of Gynecologic Oncology Group trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Influence of the gynecologic oncologist on the survival of ovarian cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Quality of care in advanced ovarian cancer: the importance of provider specialty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

Associations between hospital and surgeon procedure volumes and patient outcomes after ovarian cancer resection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.12.017

10.1016/J.YGYNO.2013.12.017

7 January 2021

Identifiers

DOI

1 reference

11 December 2017

1 reference